International experts ask and answer questions on malaria drug delivery
21 November 2015
Global health researchers engaged in discussions on ACT Consortium research at this year's meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, USA.
Photo: Prof Wilfed Mbacham, University of Yaoundé, Cameroon and ACT Consortium Principal Investigator
This year's ASTMH meeting saw the first exhibition booth hosted by the ACT Consortium, where delegates came to ask and answer questions on access, targeting, safety and quality of artemisinin-based combination therapy (ACT), the first line treatment for malaria recommended by the WHO.
Presentations
- Impact of providing rapid diagnostic malaria tests on fever management in the private retail sector in Ghana: a cluster randomized trial - Evelyn Ansah, Ghana Health Centre
- Referral from community health workers: Evidence from cluster randomized trials of mRDTs in two areas of high and low malaria transmission in Uganda - Sham Lal, London School of Hygiene & Tropical Medicine (LSHTM)
Examining referrals from communities to health centers from ACT Consortium on Vimeo.
- Science journalism of tropical diseases - Debora Miranda, LSHTM
- Effects of introducing malaria rapid diagnostic tests in drug shops: Findings from the evaluation of a cluster randomized trial in Uganda by Sian Clarke, LSHTM
Posters
- Systematic sampling approach reveals fewer falsified first line antimalarials than previously reported by Harparkash Kaur, LSHTM
- Health facility caseload changes during the introduction of community case management of malaria in South Western Uganda - An interrupted time series approach by Sham Lal, LSHTM
- Impact of malaria rapid diagnostic tests on patient care: Results from the ACT Consortium by Katia Bruxvoort, LSHTM
- Impact of malaria rapid diagnostic tests on patient's subsequent treatment-seeking, costs and health outcomes: Results from the ACT Consortium by Heidi Hopkins, LSHTM
- Modelling the cost-effectiveness of introducing malaria rapid diagnostic tests in the private for-profit sector by David Bath, LSHTM
- Use of interferon-y release assays for the diagnosis of tuberculosis in patients with concurrent malaria infection in Tanzania by Lasse Vestergaard, University of Copenhagen
Social media highlights
Prof David Schellenberg, director of the ACT Consortium, answers questions on malaria drug delivery during Twitter #TropMedChat at ASTMH
Find more questions and answers on malaria drug delivery at @ACTConsortium
Final gathering of ACT Consortium researchers
After the ASTMH meeting, the ACT Consortium hosted its final meeting. More than 40 investigators and members, as well as Dr David Brandling-Bennett from the funder Bill & Melinda Gates Foundation, discussed the key messages from 25 studies in 10 countries across Africa and Asia, and the lessons learned from this international research collaboration.
ACT Consortium members at final meeting in Philadelphia, USA on 30 October 2015
